China's MicuRx Pharma secures $107m in Series E round

China's MicuRx Pharma secures $107m in Series E round

Source: Volodymyr Hryshchenko/Unsplash

21 December, 2020

Legend Capital MicuRx Pharmaceuticals

Printed by Unregistered user on Fri, 26 Dec 2025 11:48:39 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China Deal Monitor: Huagai leads $43m in MicuRx and more updates

Venture Capital

China: Vision Plus leads $30m round in Etong Healthcare; MicuRx closes private financing deal

Read more from Greater China

UBTech buys Shenzhen-listed Fenglong Electric with eye on mainland listing

Chinese humanoid robot maker Deep Robotics files for mainland IPO